The Bioinsecticides Market is projected to expand at a CAGR of 15.6%, reaching USD 4.247 billion in 2031 from USD 2.056 billion in 2026.
Highlights:
1
Bacillus thuringiensis represents approximately 41% of 2026 value, underpinned by established caterpillar-control use.
2
Caterpillar-targeted products account for an estimated 48% of demand across insect-control applications in 2026.
3
Liquid formulations represent around 56% of 2026 sales, although shelf-stable powders remain commercially relevant.
4
Fruits and vegetables contribute approximately 44% of value in 2026, reflecting residue-sensitive crop programs.
5
Brazilian biological registrations and viral insecticide investment are strengthening South America’s commercial position.
6
Successful field adoption still depends on application timing, storage stability and demonstrated pest-specific efficacy.
Full historical and forecast dataset available in Excel and dashboard formats.Download Sample Data →
Report Overview
The bioinsecticides market covers commercially supplied preparations intended to suppress agricultural insect pests using microbial, viral, botanical and other biologically derived insecticidal agents. Products are sold as liquids, wettable powders, granules and comparable formulations for foliar, soil or other label-approved use. Genetically engineered crop traits, live predator releases, biofungicides, general fertilizers and conventional synthetic insecticides are distinct markets and are not treated as bioinsecticide product sales.
The product mix serves two different purchasing environments. Fruit and vegetable growers frequently need low-residue tools that can be fitted close to harvest, while broad-acre farms prioritize reliable control of economically important larvae across large areas. Certis Biologicals supplies several Bt strains and insect-specific viruses; BASF markets Beauveria-based Velifer and added nucleopolyhedrovirus capabilities through AgBiTech. Andermatt, BioWorks and Vestaron illustrate alternative viral, fungal and peptide-based approaches, while Indian suppliers serve local demand for entomopathogenic fungi.
Market Overview
Bt remains the most established microbial insecticide platform because different strains express proteins active against defined insect groups. Spray products typically require larvae to ingest treated foliage, so scouting and treatment of early instars matter more than the simple presence of a registered product. Certis markets Bt-based Agree, Javelin and related formulations; BioSafe Systems offers BT NOW. Producers of entomopathogenic fungi instead seek infection through contact with the insect cuticle, extending their role in greenhouse and specialty-crop programs where whiteflies, thrips and aphids are persistent problems.
Innovation is widening the technologies available alongside conventional microbial strains. AgBiTech’s nucleopolyhedrovirus products address lepidopteran pests in soybean, corn and cotton, and Andermatt’s Helicovex targets Helicoverpa species. Vestaron’s BASIN uses an insecticidal peptide, while Seipasa’s Pirecris offers a naturally derived contact insecticide. These approaches do not compete on identical pest spectra: some are highly selective ingestion products, others act through contact, and all must be assessed against label restrictions and the crop’s beneficial-insect program.
Commercial adoption is ultimately determined at farm level. A biological spray that fits an existing treatment window, mixes with other permitted inputs and delivers predictable control can gain share without replacing all synthetic chemistry. Conversely, weak spray coverage or delayed application can undermine performance even when the active ingredient is well established.
Market Trends
Virus-Based Products Are Broadening Row-Crop Insect Control
Biological insect control in row crops is attracting larger suppliers that previously concentrated on specialty crops. BASF’s acquisition of AgBiTech adds manufacturing assets and nucleopolyhedrovirus products directed at caterpillar pests, particularly in Brazil. Virus-based solutions offer a distinct mode of action in resistance-management programs and can be relevant where repeated conventional applications put selection pressure on pest populations.
Large-scale field adoption will depend on whether treatment economics remain competitive when products are applied over extensive acreage. Timing against young larvae, spray coverage and the ability to coordinate applications with existing machinery are central considerations.
Fungal Formulations Are Being Designed for Practical Handling
Beauveria and related entomopathogenic fungi are gaining attention for insects that are difficult to manage with ingestion-dependent Bt sprays. BioWorks introduced PRINCIPLE WP using its BW149 strain, with a wettable-powder format and multiple labeled application routes. BASF’s Velifer provides another Beauveria option, while Koppert’s Mycotal relies on Akanthomyces muscarius for whitefly, thrips and aphid management.
Manufacturers are addressing a problem common to living microbial products: biological activity can decline when storage, humidity, ultraviolet exposure or preparation conditions depart from an optimal range. Stable formulations and clear mixing guidance reduce the risk that product quality changes between the manufacturing plant and application.
New Modes of Action Are Extending Beyond Whole Microorganisms
Peptide and metabolite technologies are expanding the definition of biological insect control beyond conventional spores and fermentation-derived whole cells. Vestaron’s BASIN approval for outdoor crops extends the possible use of its peptide-based approach beyond protected cultivation. Aphea.Bio and Bayer are also developing bioinsecticide candidates derived from microbial metabolites for sap-sucking pests, although those candidates remain at development rather than commercial deployment stage.
A non-living active may offer different formulation and supply-chain characteristics from a live organism, but efficacy, registration and cost remain product-specific. The prospective value for growers lies in additional pest-control options that can be rotated with existing products.
Regional Regulation Is Shaping Different Product Portfolios
Registration frameworks increasingly influence where biological suppliers invest in trials and manufacturing. The US Environmental Protection Agency reviews microbial and biochemical pesticides under specific biopesticide requirements, while the European Union’s integrated pest management framework encourages lower-risk approaches where they are effective. Neither framework eliminates the need for product-specific risk assessment, and a biological origin does not automatically confer approval or zero residue.
Brazil has become a particularly active commercialization market. Its agriculture ministry reported 162 registrations of products classed as bioinputs during 2025, covering several categories beyond insecticides. The increase indicates expanding regulatory throughput and supplier attention, but registrations must not be mistaken for equivalent product usage or bioinsecticide revenue.
Segment Analysis
By Type: Bacillus thuringiensis
Bt bioinsecticides are projected to reach approximately USD 1.571 billion in 2031. Established formulations remain important because growers understand their use against lepidopteran larvae and can integrate them into established spraying programs. The category is supported by differing Bt subspecies and strains with defined insect targets, allowing suppliers to offer more specialized products than a single broad-spectrum biological treatment. Certis Biologicals and BioSafe Systems have documented commercial formulations for caterpillar control.
Its relative position faces competition from fungal, viral and newer peptide technologies, yet its manufacturing experience and compatibility with integrated pest management preserve a substantial recurring market.
By Insect Type: Caterpillars
Caterpillars are the largest target group because larval feeding can quickly damage foliage, fruit and reproductive tissues across vegetable, tree-crop and row-crop systems. Bt products, insect-specific baculoviruses and selected botanical formulations each address part of this demand. Early-stage identification can materially affect the value of treatment, particularly for products whose active ingredient must be ingested.
Spending on caterpillar-directed bioinsecticides is projected at approximately USD 1.869 billion in 2031. In Brazil, the commercial case for viral control is closely linked to persistent lepidopteran pressure in soybean, cotton and corn.
By Form: Liquid
Liquid products accommodate familiar mixing, metering and spray-application practices, which can lower the operational barrier for commercial growers. Fermentation-derived suspensions and other concentrates are used where application flexibility and dispersion are important. Product chemistry still governs handling: a liquid containing living spores has different storage and compatibility requirements from a botanical extract or peptide formulation.
Liquid bioinsecticides are estimated to generate approximately USD 2.506 billion in 2031. Their expanding role does not displace water-dispersible granules or wettable powders, which can offer transport and shelf-life advantages for specific actives.
By Crop Type: Fruits & Vegetables
An estimated USD 1.784 billion of bioinsecticide revenue will originate from fruits and vegetables in 2031. These crops have high value per hectare, frequent insect pressure and limited tolerance for cosmetic damage. Harvest schedules and retailer residue requirements can make well-labeled biological products attractive late in the crop cycle, although allowable pre-harvest intervals and residue claims always depend on the individual registration.
Commercial greenhouse producers are especially attentive to compatibility with beneficial insects, repeat treatments and protected-crop application methods. Field-grown fruit and vegetable businesses face different pressures around weather exposure and spray timing.
Full historical and forecast dataset available in Excel and dashboard formats.Download Sample Data →
Market Drivers
Resistance Management in High-Pressure Pest Systems
Insects exposed repeatedly to the same chemical mode of action can become harder to control, increasing the economic value of a broader rotation program. Bt proteins, insect-specific viruses, entomopathogenic fungi and insecticidal peptides provide distinct biological mechanisms, although resistance management still requires proper use and avoidance of excessive repeat applications.
Manufacturers that supply credible field data on target species can earn a place in planned spray rotations rather than only emergency treatment. That recurring program position is more valuable than an occasional substitution driven solely by short-term chemical availability.
Residue Management in High-Value Produce
Fresh-produce exporters and retailers often impose residue specifications that affect the timing and selection of crop-protection products. Certain bioinsecticides have favorable labeled pre-harvest intervals or residue characteristics, allowing growers to manage pest pressure closer to harvest where permitted. The advantage varies by active ingredient and market authorization; natural origin alone is not a guarantee of residue exemption.
Fruit, vegetable and protected-crop producers can justify higher per-hectare spending when a treatment reduces the risk of rejected shipments or avoidable quality losses. Suppliers with locally registered labels and technical support are well placed to serve these applications.
Expansion of Integrated Pest Management Programs
Integrated pest management links monitoring, cultural practices, biological control and appropriately selected pesticides. Bioinsecticides fit this approach when scouting identifies a susceptible pest stage and the treatment can be coordinated with predators, parasitoids and conventional chemistry.
Repeated exposure to biological products through structured programs improves distributor knowledge and farm-level confidence. Once products become routine elements of an agronomy protocol, suppliers benefit from more predictable seasonal orders and clearer evidence of effective use.
Local Manufacturing and Registration Growth in Brazil
Brazil’s extensive soybean, corn, sugarcane and cotton production creates a demanding environment for insect-control innovation. The national bioinputs framework and an expanding registration pipeline encourage domestic supply and adaptation to local pests. AgBiTech’s established Brazilian operations were an important strategic element of BASF’s 2026 acquisition, illustrating the commercial value of established field networks and production assets.
Not every newly registered biological is an insecticide, and registration is not proof of sales. Nevertheless, an enlarging portfolio of legally available products makes it easier for distributors and growers to build multi-product biological programs across growing seasons.
Better Formulations and Wider Labeled Uses
Fermentation advances, granulation and stabilizing additives are helping manufacturers improve the storage and handling of microbial products. BioWorks’ BW149 formulation and the expansion of allowed use patterns for other biological insecticides show how product engineering can address practical grower constraints.
These developments matter because farmers often compare a biological with an existing spray program rather than with a laboratory control. More convenient handling, reliable concentration and clear mixing instructions can reduce the perceived cost of adoption even when unit prices remain above older synthetic alternatives.
Many microbial insecticides respond strongly to ultraviolet light, temperature, humidity or rainfall, and product performance can vary by insect species or developmental stage. Bt sprays generally need ingestion by susceptible larvae; fungal products require suitable conditions for infection. Applying a product late in an outbreak can produce disappointing results despite good underlying efficacy.
The consequence is higher field-service demand and a need for repeated demonstrations across local environments. Growers with narrow treatment windows may retain conventional insecticides where biological control cannot provide adequate reliability under prevailing conditions.
Manufacturing Quality and Biological Viability
Commercial microbial production requires controlled fermentation, strain integrity, downstream processing and batch-level potency testing. Contamination or changes in viability can compromise a biological product in ways not apparent from packaging.
Scale brings cost advantages only if the process remains reproducible. Smaller suppliers may struggle to fund process validation and quality systems while competing with established companies that already operate fermentation facilities and registered portfolios.
Higher Perceived Program Cost for Broad-Acre Growers
Bioinsecticides can carry a purchase-price premium, and some require several precisely timed applications to achieve reliable suppression. For high-value fruit, the value of avoiding crop rejection may justify the expenditure. Large-acre cereal and oilseed producers instead assess cost per hectare against pest thresholds, labor availability and the capacity of existing spray equipment.
A product priced attractively per container can still be uneconomic if coverage, application frequency or scouting requirements substantially raise the total program cost. Adoption therefore depends on demonstrated yield protection rather than biological positioning alone.
Registration, Label and Export-Market Differences
Active ingredients approved in one jurisdiction may lack registration for the same crops, pest species or use patterns in another. Microbial strain identity, environmental risk, residue requirements and product composition can all influence regulatory treatment.
Differences among authorized labels also complicate product comparison for growers operating across countries. A company with strong scientific data may still need substantial capital and several seasons of trials before an additional market contributes material revenue.
Distributor Training and Application Discipline
Some biological insecticides require more precise scouting, mixing and spray timing than products growers have used for years. Incorrect water pH, poor coverage or storage beyond the labeled conditions can reduce effectiveness before the active ingredient reaches the target pest.
Manufacturers expanding through general agricultural channels must finance training, demonstration plots and complaint resolution. Without that support, early unsuccessful applications can limit repeat purchasing and slow geographic expansion even in regions with favorable regulation.
Regional Outlook
Full historical and forecast dataset available in Excel and dashboard formats.Download Sample Data →
North America
Commercial fruit and vegetable production, protected horticulture, established biological suppliers and regulated low-residue products support North American bioinsecticide demand. The United States is a center for microbial and peptide product development, with companies such as Certis Biologicals, BioWorks and Vestaron operating within a structured EPA registration environment.
North America is estimated to represent 29% of global bioinsecticide value in 2026. Demand is particularly resilient where multiple harvests, retailer residue requirements or difficult-to-control greenhouse insects raise the cost of losing product quality. Supplier investments in proprietary strains, new application methods and distributor advice support adoption, while Canada and Mexico extend the region’s market through horticulture and cross-border supply chains.
South America
South America is expected to record an estimated 19.23% CAGR during 2026–2031, with Brazil accounting for most regional demand. Soybean, corn and cotton systems create a large opportunity for microbial and viral insecticides aimed at recurring caterpillar pressure, while sugarcane and horticulture support other biological technologies. Brazil’s growing bioinputs registration system has broadened product availability; actual adoption still depends on crop economics, registered targets and local field results.
The integration of AgBiTech into BASF highlights the region’s strategic importance because viral insect control can be combined with established agricultural distribution and manufacturing. Local suppliers also compete on cost, strain suitability and agronomic service. South America’s expanding share is likely to be concentrated among companies that deliver dependable performance on large-acreage crops without requiring application practices incompatible with existing farm operations.
Competitive Landscape
The bioinsecticides supplier base spans multinational crop-protection companies, microbial formulation specialists, producers of insect-specific viruses and developers of newer biological actives. BASF now combines Beauveria-based Velifer with AgBiTech’s viral technologies. Certis Biologicals maintains a broad portfolio across Bt strains, fungal insecticides and insect-specific viruses, while BioWorks focuses on greenhouse and specialty-crop solutions.
Andermatt competes through targeted viral products, Vestaron through insecticidal peptides and Koppert through microbial insecticides integrated with wider biocontrol programs. BioSafe Systems and Seipasa offer insecticides of bacterial or botanical origin, while IPL Biologicals and T. Stanes address demand for fungal biopesticides in India.
Recent Developments
12 August 2026: Aphea.Bio announced a research partnership with Bayer to develop microbial-metabolite bioinsecticide candidates against sap-sucking pests. The program is at a development and field-validation stage rather than commercial launch.
2 April 2026: Andermatt reported Australian regulatory approval for reduced rates of its Helicovex baculovirus bioinsecticide against Helicoverpa pests, providing additional flexibility for labeled IPM programs.
31 March 2026: BASF completed its acquisition of AgBiTech, adding insect-specific virus products, production facilities and field capabilities in markets including Brazil.
17 February 2026: Vestaron announced US EPA approval for outdoor agricultural use of BASIN, extending the applications of its peptide-based bioinsecticide beyond greenhouse and indoor crops.
20 October 2025: Sumitomo Chemical announced the consolidation of its US biorational businesses into Sumitomo Biorational Company, with operations scheduled to commence in April 2026; the restructure brings crop-related biological expertise within a broader biorational platform.
11 April 2025: BioWorks announced US EPA approval of PRINCIPLE WP, a Beauveria bassiana BW149 bioinsecticide labeled for several indoor and outdoor application methods.
Market Outlook
The bioinsecticides market is likely to become more diverse in active ingredients and less concentrated around a handful of traditional microbial formulations. Bt will retain a substantial role in caterpillar management, while viruses, fungi, peptides and selected botanical products will provide alternatives for pest groups that require different application mechanisms.
Specialty crops will remain valuable because growers face demanding residue and quality requirements, but broad-acre growth will increasingly depend on the economics of viral and other targeted treatments in Brazil and comparable agricultural systems. South American expansion will test whether biological products can achieve consistent performance over large areas and across variable field conditions.